Juvic Inc. is a biotechnology company developing next-generation microneedle delivery platforms engineered for efficient, reproducible intradermal delivery of vaccines, biologics, and nucleic acid therapeutics.

Its proprietary candle-shaped microneedle structure enables precise dosing, rapid dissolution, and enhanced bioavailability, overcoming major limitations of conventional injections and transdermal systems.

The platform is designed to improve immunogenicity, support thermostable formulations, and reduce administration complexity—making it well suited for global vaccine deployment and emerging biologic therapies.

Beyond healthcare applications, Juvic has validated its microfabrication technology through dermatological products under the NeeDeep® brand, demonstrating scalability, safety, and consumer-ready design.